Plaintiffs lawyers hoping to revive 3,128 lawsuits over cholesterol drug Lipitor have asked an appeals court to overturn what they consider to be a heightened standard on expert evidence — one they said could hasten the demise of other multidistrict litigation.
It’s a battle that’s been fought before: Lawyers at the same appellate firm, Washington’s Kellogg, Hansen, Todd, Figel & Frederick, lost a similar argument on June 2 before the U.S. Court of Appeals for the Third Circuit, which affirmed dismissal of 315 lawsuits brought over Zoloft. Partner David Frederick argued that case for the plaintiffs. Now, his colleague, Derek Ho, is going before the Fourth Circuit against the same defendant, Pfizer Inc., which is represented once again by Mark Cheffo of Quinn Emanuel Urquhart & Sullivan in New York.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
